eisai.mediaroom.com

Xenetic is also developing a broad pipeline of clinical candidates for next generation ... and novel oncology therapeutics in a number of orphan disease indications. ... Eisai US. Фармацевтическая промышленность. 1 001-5 000 сотрудников ...

  ru.linkedin.com

  www.eisai.com

  us.eisai.com

Stay on top of all the news and developments in your area of interest. REQUEST INFORMATION Presentation Jobs.

  oncologypipeline.com

  eisaioncologypipeline.com

3 авг 2018 ... epizyme-pipeline .... подружилась с «Гритстоун онколоджи» (Gritstone Oncology) с целью поиска новых мишеней в рамках TCR-терапии и ...

  mosmedpreparaty.ru

  eisai.mediaroom.com

Oct 10, 2018 TOKYO, Oct 10, 2018 (JCN Newswire via COMTEX) -- Eisai Co., Ltd. announced today that a series of abstracts highlighting updates regarding its in-house discovered Lenvima/Kisplyx...

  www.marketwatch.com

  studyres.com

13 янв 2019 ... ... and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial. ... 4Eisai, Woodcliff Lake, NJ;.

  www.researchgate.net

  www.scribd.com

Page generated - 0.0969281197 (b3cc00f60efaa3af1ba0ef6793376ae8)